Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201110196 Principal Investigator: Waqar, Saiama
Title: A Randomized, Phase III, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Onartuzumab (MetMAb) in Combination with Tarceva; (Erlotinib) in Patients with Met Diagnostic-Positive Non-Small Cell Lung Cancer (NSCLC) who Have Received Standard Chemotherapy for Advanced or Metastatic Disease
Phase: III Disease Site: Lung
Participating Site(s):
 
Main Campus
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is help to determine whether a humanized antibody (MetMAb) is safe and effective when given to patients with advanced NSCLC in combination with erlotinib, a drug that is commonly used to treat this type of cancer.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)